CANNABIS REMAINS PROBLEMATIC FOR GLAUCOMA: Drawbacks, limited research shadow potential benefits.
| Publicado en: | Ophthalmology Times Vol. 42; no. 14; pp. 11 - 13 |
|---|---|
| Autores principales: | , |
| Formato: | pictorial Journal Article |
| Publicado: |
MJH Life Sciences
9/1/2017
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=125086852&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 125086852 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 0193032X OTI jtl: Ophthalmology Times issn: 0193032X maglogo: N pubinfo: dt: 9/1/2017 vid: 42 iid: 14 pid: 54670 pub: MJH Life Sciences place: Cranbury, New Jersey artinfo: ui: 125086852 125086852 125086852 125086852 ppf: 11 ppct: 2 formats: fmt: @attributes: type: P tig: atl: CANNABIS REMAINS PROBLEMATIC FOR GLAUCOMA: Drawbacks, limited research shadow potential benefits. aug: au: Harrison, Laird Radhakrishnan, Sunita sug: subj: Glaucoma Drug Therapy Treatment Outcomes Intraocular Pressure Medical Marijuana Pharmacodynamics Cannabis Legislation and Jurisprudence pubtype: Trade Publication doctype: pictorial Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|